You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Claims for Patent: 8,110,547


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,110,547
Title:Compositions for buccal delivery of parathyroid hormone
Abstract: Compositions and pharmaceutical formulations for buccally delivering parathyroid hormone comprising a) a delivery agent, b) a PTH component and, optionally, c) an antiresorptive agent are provided.
Inventor(s): Lee; Jongbin (New City, NY), Liu; Puchun (Chappaqua, NY), Dinh; Steven (Briarcliff Manor, NY)
Assignee: Emisphere Technologies, Inc. (Cedar Knolls, NJ)
Application Number:11/813,700
Patent Claims:1. A pharmaceutical composition for administration through the cheek lining comprising (a) a delivery agent selected from 4-MOAC, and pharmaceutically acceptable salts thereof, and (b) a parathyroid hormone component, wherein the composition is free of calcitonin.

2. The composition of claim 1, wherein the delivery agent is a monosodium salt of 4-MOAC.

3. A method for preventing or treating osteoporosis in a patient in need thereof comprising administering through the cheek lining an effective amount of a pharmaceutical composition comprising (a) a delivery agent selected from 5-CNAC, 4-MOAC, and pharmaceutically acceptable salts thereof, and (b) a parathyroid hormone component, wherein the composition is free of calcitonin.

4. A method of stimulating new bone formation in a patient comprising administering through the cheek lining an effective amount of a pharmaceutical composition comprising (a) a delivery agent selected from 5-CNAC, 4-MOAC, and pharmaceutically acceptable salts thereof, and (b) a parathyroid hormone component, wherein the composition is free of calcitonin.

5. A method for treating hypoparathyroidism in a patient in need thereof comprising administering through the cheek lining an effective amount of a pharmaceutical composition comprising (a) a delivery agent selected from 5-CNAC, 4-MOAC, and pharmaceutically acceptable salts thereof, and (b) a parathyroid hormone component, wherein the composition is free of calcitonin.

6. The method of claim 3, wherein the delivery agent is 5-CNAC, or a pharmaceutically acceptable salt thereof.

7. The method of claim 4, wherein the delivery agent is 5-CNAC, or a pharmaceutically acceptable salt thereof.

8. The method of claim 5, wherein the delivery agent is 5-CNAC, or a pharmaceutically acceptable salt thereof.

9. The method of claim 6, wherein the delivery agent is a monosodium salt of 5-CNAC.

10. The method of claim 7, wherein the delivery agent is a monosodium salt of 5-CNAC.

11. The method of claim 8, wherein the delivery agent is a monosodium salt of 5-CNAC.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.